Malic Acid

Malic Acid

SCHEMBL261732

C=C(C)C(=O)OCCCO.O=C(O)CC(O)C(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDRD2HTR1BHTR1DHTR1F

The experimentally established mechanism targets of Malic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
THRB P10828 1/20 0.40
POLB P06746 1/20 0.40
APEX1 P27695 1/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TET2 Q6N021 3/20 0.37
TET3 O43151 1/20 0.37
TET1 Q8NFU7 1/20 0.37
ALDH1A1 P00352 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
OR51E2 Q9H255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malic Acid SCHEMBL260319 0.91 SMN1; SMN2 (0.48) TSHRSMN1; SMN2THRBPOLBAPEX1
Malic Acid SCHEMBL9188596 0.85 THRB (0.49) TSHRSMN1; SMN2THRBPOLBAPEX1
Malic Acid SCHEMBL29711798 0.84 THRB (0.54) TSHRSMN1; SMN2THRBPOLBAPEX1
SCHEMBL15480 0.82 TSHR (0.64) TSHRTHRBPOLBAPEX1HTT
Methacrylic Acid SCHEMBL10956928 0.80 TSHR (0.58) TSHRTHRBPOLBAPEX1HTT
Methacrylic Acid SCHEMBL10953673 0.80 TSHR (0.58) TSHRTHRBPOLBAPEX1HTT
Methacrylic Acid SCHEMBL4362961 0.80 TSHR (0.58) TSHRTHRBPOLBAPEX1HTT
Water SCHEMBL7119412 0.80 TSHR (0.62) TSHRTHRBPOLBAPEX1HTT
Lithium SCHEMBL31087663 0.80 TSHR (0.62) TSHRTHRBPOLBAPEX1HTT
Potassium SCHEMBL31087662 0.80 TSHR (0.62) TSHRTHRBPOLBAPEX1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667730-B2 Oxime ester compound and photopolymerization initiator containing the same ADEKA CORPORATION (JP) 2023-06-06 US disclosed
WO-2022075452-A1 COMPOUND, POLYMERIZATION INITIATOR, POLYMERIZABLE COMPOSITION, CURED PRODUCT, COLOR FILTER AND METHOD FOR PRODUCING CURED PRODUCT 株式会社ADEKA 2022-04-14 WO disclosed
EP-3339331-B1 COMPOSITION ADEKA CORP (JP) 2022-02-16 EP disclosed
CN-106132929-B Oxime ester compound and photopolymerization initiator containing the same 株式会社艾迪科 2020-06-19 CN disclosed
EP-3176153-B1 NOVEL POLYMERIZATION INITIATOR AND RADICALLY POLYMERIZABLE COMPOSITION CONTAINING SAME ADEKA CORP (JP) 2020-04-08 EP disclosed
US-10189847-B2 Oxime ester compound and photopolymerization initiator containing said compound ADEKA CORPORATION (JP) 2019-01-29 US disclosed
EP-3339331-A1 COMPOSITION Adeka Corporation (JP) 2018-06-27 EP disclosed
US-10005851-B2 Polymerization initiator and radically polymerizable composition containing same ADEKA CORPORATION (JP) 2018-06-26 US disclosed
US-20170283520-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2017-10-05 US disclosed
US-20170166575-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SAID COMPOUND ADEKA CORPORATION (JP) 2017-06-15 US disclosed
EP-2145880-B1 NOVEL EPOXY COMPOUND, ALKALI-DEVELOPABLE RESIN COMPOSITION, AND ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION ADEKA CORP (JP) 2011-09-28 EP disclosed
US-7846622-B2 Alkali-developable, colored photosensitive resin composition and color filter using the alkali-developable, colored photosensitive resin composition TOPPAN PRINTING CO., LTD. (JP) 2010-12-07 US disclosed
EP-2223910-A1 OXIME ESTERS AND PHOTOPOLYMERIZATION INITIATORS CONTAINING THE SAME Adeka Corporation (JP) 2010-09-01 EP disclosed
US-20100075254-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2010-03-25 US disclosed
US-20100015551-A1 NOVEL EPOXY COMPOUND, ALKALI-DEVELOPABLE RESIN COMPOSITION, AND ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION ADEKA CORPORATION (JP) 2010-01-21 US disclosed
EP-2145880-A1 NOVEL EPOXY COMPOUND, ALKALI-DEVELOPABLE RESIN COMPOSITION, AND ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION Adeka Corporation (JP) 2010-01-20 EP disclosed
EP-2128132-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR COMPRISING THE COMPOUND Adeka Corporation (JP) 2009-12-02 EP disclosed
US-20090292039-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME ADEKA CORPORATION (JP) 2009-11-26 US disclosed
EP-2072500-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE COMPOUND Adeka Corporation (JP) 2009-06-24 EP disclosed
US-20070269720-A1 Alkali-Developable, Colored Photosensitive Resin Composition and Color Filter Using The Alkali-Developable, Colored Photosensitive Resin Composition TOPPAN PRINTING CO., LTD. (JP) 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667730-B2 Oxime ester compound and photopolymerization initiator containing the same OXER1, CYP4A11, CYP4F11 TSHR 344/4885SMN1; SMN2 3768/4885THRB 402/4885
US-20100075254-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME CYP4A11, OXER1, NR2E3 TSHR 315/4885SMN1; SMN2 2596/4885THRB 312/4885
US-20170166575-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SAID COMPOUND RB1, PRMT9, KDM2B TSHR 1830/4885SMN1; SMN2 1051/4885THRB 3428/4885
US-10189847-B2 Oxime ester compound and photopolymerization initiator containing said compound PPOX, CCNO, MRTO4 TSHR 2007/4885SMN1; SMN2 1372/4885THRB 2982/4885
US-20090292039-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME OXER1, CYP4A11, CYP4F11 TSHR 429/4885SMN1; SMN2 3821/4885THRB 421/4885
US-10005851-B2 Polymerization initiator and radically polymerizable composition containing same CYBA, CCNT1, SPTBN1 TSHR 4808/4885SMN1; SMN2 1607/4885THRB 4509/4885
US-20170283520-A1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME OXER1, CYP4A11, CYP4F11 TSHR 344/4885SMN1; SMN2 3768/4885THRB 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.